MARY NELSON SABO: Open Payments
NPI 1942791074 · CLIO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 25 payments from 12 companies in 2025. Trend: 2023 $484 · 2024 $367 · 2025 $431
Food & beverage: $404Education: $28
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Amgen Inc. | 4 | $65 |
| PFIZER INC. | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $15 |
Products named: OTEZLA, NURTEC ODT, EOHILIA, REXULTI, BREZTRI, Kerendia, The Cologuard Plus Collection Kit, FUROSCIX.
Industry payments across MI — which companies pay providers there.
